These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7433509)

  • 1. In vitro dissolution of different brands of griseofulvin tablets.
    Khalafalla N
    Pharmazie; 1980; 35(9):555-8. PubMed ID: 7433509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of different brands of griseofulvin tablets and its correlation to dissolution data.
    Khalafalla N; Elgholmy ZA; Khalil SA
    Pharmazie; 1980 Aug; 35(8):482-4. PubMed ID: 7433499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolution test for citalopram in tablets and comparison of in vitro dissolution profiles.
    Menegola J; Steppe M; Schapoval EE
    Eur J Pharm Biopharm; 2007 Sep; 67(2):524-30. PubMed ID: 17398084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report: in vitro dissolution studies of different brands of sustained release diclofenac sodium matrix tablet available in Bangladesh.
    Abdullah MD; Bepary S; Rouf AS
    Pak J Pharm Sci; 2008 Jan; 21(1):70-7. PubMed ID: 18166523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC; Fadda HM; Parsons GE; Basit AW
    Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin.
    Ahmed IS; Aboul-Einien MH
    Eur J Pharm Sci; 2007 Sep; 32(1):58-68. PubMed ID: 17628451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution kinetics of bezafibrate in two solid forms for oral administration.
    Cadorniga R; Hernanez MT; Negro S; Burgos ML; Molina IT
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():371-8. PubMed ID: 1820910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution test for lamivudine tablets: optimization and statistical analysis.
    Fernandes C; Junqueira RG; Campos LM; Pianetti GA
    J Pharm Biomed Anal; 2006 Nov; 42(5):601-6. PubMed ID: 16797911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a dissolution medium for nimodipine tablets based on bioavailability evaluation.
    He Z; Zhong D; Chen X; Liu X; Tang X; Zhao L
    Eur J Pharm Sci; 2004 Mar; 21(4):487-91. PubMed ID: 14998579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pH on disintegration and dissolution of ketoconazole tablets.
    Carlson JA; Mann HJ; Canafax DM
    Am J Hosp Pharm; 1983 Aug; 40(8):1334-6. PubMed ID: 6310994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative dissolution rate studies of commercial furosemide tablets.
    Gadalla MA; Ismail AA
    Pharmazie; 1981 Aug; 36(8):553-6. PubMed ID: 7291288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diclofenac sodium multisource prolonged release tablets--a comparative study on the dissolution profiles.
    Bertocchi P; Antoniella E; Valvo L; Alimonti S; Memoli A
    J Pharm Biomed Anal; 2005 Apr; 37(4):679-85. PubMed ID: 15797788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PH-dependent drug release from certain commercial tablets.
    Sutton JE; Lach JL; Wagner RS
    Am J Hosp Pharm; 1977 Dec; 34(12):1323-6. PubMed ID: 23005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations in the development of an in vitro dissolution condition for lacidipine tablets: in vivo pharmacokinetic evaluation.
    Sun M; Sun J; He S; Wang Y; Sun Y; Liu X; He Z
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1099-106. PubMed ID: 22188158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of oral absorption of griseofulvin, a BCS class II drug, based on GITA model: utilization of a more suitable medium for in-vitro dissolution study.
    Fujioka Y; Kadono K; Fujie Y; Metsugi Y; Ogawara K; Higaki K; Kimura T
    J Control Release; 2007 Jun; 119(2):222-8. PubMed ID: 17442444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs.
    Park SH; Choi HK
    Int J Pharm; 2006 Sep; 321(1-2):35-41. PubMed ID: 16797892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the melt granulation technique on the dissolution characteristics of griseofulvin.
    Yang D; Kulkarni R; Behme RJ; Kotiyan PN
    Int J Pharm; 2007 Feb; 329(1-2):72-80. PubMed ID: 17027207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles.
    Wong SM; Kellaway IW; Murdan S
    Int J Pharm; 2006 Jul; 317(1):61-8. PubMed ID: 16647232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.